{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:47:51Z","timestamp":1791067671061,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ejogrb.2020.02.014","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:51:26Z","timestamp":1582293086000},"page":"163-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["Oral contraceptives use and risk of cervical cancer\u2014A systematic review &amp; meta-analysis"],"prefix":"10.1016","volume":"247","author":[{"given":"Smita","family":"Asthana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Busa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyanarayana","family":"Labani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.02.014_bib0005","series-title":"Global cancer observatory: cancer today","author":"Ferlay","year":"2018"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0010","first-page":"158","article-title":"OC practice guidelines: minimizing side effects","volume":"1","author":"Darney","year":"1997","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Stud Fam Plann"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0020","doi-asserted-by":"crossref","first-page":"e0205927","DOI":"10.1371\/journal.pone.0205927","article-title":"Tracing long-term trajectories of contraceptive practice across 185 countries","volume":"13","author":"Rana","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0025","first-page":"1","article-title":"Use of contraception and use of family planning services in the United States: 1982\u20132002","volume":"350","author":"Mosher","year":"2004","journal-title":"Adv Data"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0030","first-page":"1868","article-title":"Clinical relevance in present day hormonal contraception","volume":"37","author":"Regidor","year":"2018","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5455\/msm.2018.30.131-135","article-title":"The prevalence of the most important risk factors associated with cervical cancer","volume":"30","author":"Lukac","year":"2018","journal-title":"Mater Sociomed"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0040","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/jmwh.12179_3","article-title":"Large prospective study finds no association between oral contraceptive use and breast cancer but increased risk for cervical cancer","volume":"59","author":"Bond","year":"2014","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0050","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1054\/bjoc.1999.1100","article-title":"Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection","volume":"82","author":"Kjellberg","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/jog.13291","article-title":"Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis","volume":"43","author":"Peng","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0060","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0029-7844(95)00022-J","article-title":"Net effect of oral contraceptive use on the risk of cancer in women in the United States","volume":"85","author":"Schlesselman","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/00016349209021075","article-title":"Oral contraceptives and cancer of the cervix uteri. A meta-analysis","volume":"71","author":"Delgado-Rodriguez","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0075","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","article-title":"Cervical cancer and use of hormonal contraceptives: a systematic review","volume":"361","author":"Smith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ije\/19.1.4","article-title":"Oral contraceptive use and risk of invasive cervical cancer","volume":"19","author":"Brinton","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.2910550211","article-title":"Invasive squamous cell cervical carcinoma and combined oral contraceptives: results from a multinational study WHO collaborative study of neoplasia and steroid contraceptives","volume":"55","author":"Berry","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0095","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner\u2019s oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0100","first-page":"513","article-title":"Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use","volume":"4","author":"Kjaer","year":"1993","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0105","first-page":"1079","article-title":"Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas","volume":"8","author":"Lacey","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0110","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0959-8049(97)10139-3","article-title":"Time since last use of oral contraceptives and risk of invasive cervical cancer","volume":"34","author":"Parazzini","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ije\/19.2.259","article-title":"Oral contraceptive use and invasive cervical cancer","volume":"19","author":"Parazzini","year":"1990","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0120","doi-asserted-by":"crossref","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.aje.a008923","article-title":"Oral contraceptives and invasive adenocarcinomas and adeno-squamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"144","author":"Thomas","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0010-7824(91)90010-D","article-title":"The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries","volume":"43","author":"Thomas","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0135","doi-asserted-by":"crossref","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","article-title":"Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study","volume":"9","author":"Urban","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0140","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0140-6736(94)90567-3","article-title":"Oral contraceptive use and adenocarcinoma of cervix","volume":"344","author":"Ursin","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0145","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.7314\/APJCP.2014.15.14.5517","article-title":"Risk of cancer with combined oral contraceptive use among Iranian women","volume":"15","author":"Vaisy","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0150","first-page":"7","article-title":"Effect of oral contraceptives on risk of cervical cancer","volume":"91","author":"Vanakankovit","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0155","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2013.08.008","article-title":"Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study","volume":"88","author":"Vessey","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ije\/24.1.19","article-title":"Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives","volume":"24","author":"Ye","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.0.CO;2-1","article-title":"Smoking and oral contraceptives as risk factors for cervical carcinoma in situ","volume":"81","author":"Ylitalo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0175","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/bjc.1996.247","article-title":"Oral contraceptives and cervical cancer--further findings from the Oxford Family Planning Association contraceptive study","volume":"73","author":"Zondervan","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0180","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0185","series-title":"CASP Systematic Review Checklist. Available at: https:\/\/casp-uk.net\/casp-tools-checklists\/. Published 2018. Last accessed on September 13","author":"Critical Appraisal Skills Programme","year":"2019"},{"issue":"1","key":"10.1016\/j.ejogrb.2020.02.014_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2188\/jea.JE20150047","article-title":"Association of combined tobacco smoking and oral contraceptive use with cervical intraepithelial neoplasia 2 or 3 in Korean women","volume":"26","author":"Oh","year":"2016","journal-title":"J Epidemiol"},{"issue":"February 2","key":"10.1016\/j.ejogrb.2020.02.014_bib0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2012.11.003","article-title":"The role of co-factors in the progression from human papillomavirus infection to cervical cancer","volume":"128","author":"Luhn","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.02.014_bib0200","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000320742","article-title":"Hormonal contraceptives and the length of their use are not independent risk factors for high-risk HPV infections or high-grade CIN","volume":"71","author":"Longatto-Filho","year":"2011","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.ejogrb.2020.02.014_bib0205","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajog.2009.01.030","article-title":"Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection","volume":"200","author":"Harris","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2020.02.014_bib0210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ijc.21279","article-title":"Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology","volume":"117","author":"Castle","year":"2005","journal-title":"Int J Cancer"},{"issue":"18","key":"10.1016\/j.ejogrb.2020.02.014_bib0215","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/94.18.1406","article-title":"A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women","volume":"94","author":"Castle","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"9312","key":"10.1016\/j.ejogrb.2020.02.014_bib0220","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(02)08150-3","article-title":"Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group","volume":"359","author":"Moreno","year":"2002","journal-title":"Lancet"},{"issue":"June 5","key":"10.1016\/j.ejogrb.2020.02.014_bib0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/152460901300233911","article-title":"Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development","volume":"10","author":"Coker","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"issue":"March 3","key":"10.1016\/j.ejogrb.2020.02.014_bib0230","first-page":"171","article-title":"Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix","volume":"10","author":"Madeleine","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"April 7","key":"10.1016\/j.ejogrb.2020.02.014_bib0235","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1054\/bjoc.1999.1100","article-title":"Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection","volume":"82","author":"Kjellberg","year":"2000","journal-title":"Br J Cancer"},{"issue":"Dec 11","key":"10.1016\/j.ejogrb.2020.02.014_bib0240","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1054\/bjoc.2000.1523","article-title":"Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort","volume":"83","author":"Deacon","year":"2000","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2020.02.014_bib0245","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0027-5107(94)90249-6","article-title":"The role of HPV in the etiology of cervical cancer","volume":"305","author":"Mu\u00f1oz","year":"1994","journal-title":"Mutat Res"},{"key":"10.1016\/j.ejogrb.2020.02.014_bib0250","series-title":"Oral contraceptives and cancer risk","year":"2019"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520300828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520300828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:48:20Z","timestamp":1759556900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520300828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":50,"alternative-id":["S0301211520300828"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.02.014","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral contraceptives use and risk of cervical cancer\u2014A systematic review & meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}